Online citations, reference lists, and bibliographies.
← Back to Search

The Role Of Extrapleural Pneumonectomy In Malignant Pleural Mesothelioma. A Lung Cancer Study Group Trial.

V. Rusch, S. Piantadosi, E. Holmes
Published 1991 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant pleural mesothelioma is usually a fatal cancer for which operation has been the mainstay of treatment because chemotherapy and radiation are relatively ineffective. The choice of operation for malignant pleural mesothelioma remains controversial. Extrapleural pneumonectomy has been advocated because it allows complete removal of gross tumor and can be associated with long-term survival. To evaluate extrapleural pneumonectomy, we conducted a prospective multiinstitutional trial in patients with biopsy-proved previously untreated malignant pleural mesothelioma. Criteria for extrapleural pneumonectomy were (1) potentially completely resectable unilateral disease by computed tomography scan, (2) predicted postresection forced expiratory volume in 1 second greater than 1 L/sec, and (3) no other major medical problems. Patients who were not candidates for extrapleural pneumonectomy had a more limited operation with or without adjuvant therapy or had nonsurgical treatment. From September 1985 to June 1988 83 eligible patients (64 male, 19 female) were entered. The mean age for all patients was 59.7 years. Only 20 of the 83 patients (24%) underwent extrapleural pneumonectomy. Three of these 20 patients (15%) died postoperatively. The recurrence-free survival was significantly longer for the patients undergoing extrapleural pneumonectomy than for the other two groups (p = 0.03), but there was no difference in overall survival among the three groups. In univariate analyses, epithelial versus sarcomatoid and mixed histologic findings and platelet count less than 400,000 were associated with a better overall survival (p = 0.02), and performance status (Karnofsky less than 80) was predictive of recurrence (p = 0.02). In a multivariate analysis, histologic findings, sex, age, extrapleural pneumonectomy, weight loss, and performance status all had no significant impact on survival. Extrapleural pneumonectomy was associated with a greater likelihood of relapse in distant sites than were limited operation and nonsurgical treatment. We conclude that (1) only a small proportion of all patients with malignant pleural mesothelioma are candidates for extrapleural pneumonectomy, (2) extrapleural pneumonectomy carries a significant operative mortality and does not seem to improve overall survival compared with more conservative forms of treatment, (3) extrapleural pneumonectomy alters the patterns of relapse, and (4) factors previously thought to have an impact on survival in other series did not affect outcome in this trial.
This paper references
10.1136/thx.39.4.255
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.
M. Law (1984)
10.1093/AJCP/82.1.15
Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study.
V. Adams (1984)
10.1136/thx.44.6.496
Malignant pleural mesothelioma in western Glasgow 1980-6.
G. Hulks (1989)
10.1200/JCO.1988.6.3.527
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.
A. Alberts (1988)
10.1016/S0022-5223(19)38932-9
Surgical treatment of pleural mesothelioma.
P. McCormack (1982)
10.1200/JCO.1988.6.1.147
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
K. Antman (1988)
10.1016/S0022-5223(19)39080-4
Modern thirty-day operative mortality for surgical resections in lung cancer.
R. Ginsberg (1983)
Regression models and life tables (with discussion
D. Cox (1972)
10.7326/0003-4819-96-6-746
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.
A. Chahinian (1982)
10.1016/0007-0971(76)90039-5
Distant visceral metastases in pleural mesothelioma.
G. H. Roberts (1976)
10.1016/S0003-4975(10)64593-6
Extrapleural pneumonectomy for diffuse, malignant mesothelioma.
M. Davalle (1986)
10.1200/JCO.1989.7.8.1157
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
P. Ruffié (1989)
10.1055/S-0028-1102795
Möglichkeiten und Ergebnisse der chirurgischen Behandlung des malignen Pleuramesothelioms
H. Wörn (1974)
10.1016/S0003-4975(10)60855-7
Clinical staging and the tendency of malignant pleural mesotheliomas to remain localized.
R. Nauta (1982)
10.1093/JNCI/22.4.719
Statistical aspects of the analysis of data from retrospective studies of disease.
N. Mantel (1959)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.5555/URI:PII:0093775481900427
Mesothelioma--the role for radiation therapy.
L. Brady (1981)
10.1007/978-1-4612-4380-9_25
Nonparametric Estimation from Incomplete Observations
E. L. Kaplan (1958)
10.1002/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0.CO;2-5
Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases
V. Adams (1986)



This paper is referenced by
10.1016/S0003-4975(00)02394-8
Our contributions: scholarship revisited.
R. P. Scott (2001)
10.1007/S002680020021
Treatment of Malignant Mesothelioma
M. Jaklitsch (2001)
10.1200/JCO.1998.16.1.145
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
D. Curran (1998)
10.1016/S1470-2045(17)30459-X
Radiotherapy for the treatment of malignant pleural mesothelioma.
M. Perrot (2017)
10.1007/978-3-319-52619-5_36-1
Radiation Therapy in Mesothelioma
Jonas Willmann (2019)
10.1007/978-3-642-72041-3_26
Chirurgische Therapie der primären und sekundären Pleuratumoren
P. Schneider (1998)
10.3779/J.ISSN.1009-3419.2010.01.10
Analysis of the Effect of Radiotherapy on Malignant Pleural Mesothelioma when Given on Adjuvant or Palliative Basis
Hesham A. El Hossieny (2010)
10.1097/JTO.0b013e3181b9eb85
Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques
Christine E Hill-Kayser (2009)
10.2995/JACSURG.17.771
Postoperative therapies of diffuse malignant plural mesothelioma
S. Mega (2003)
10.1111/j.1440-1827.2011.02778.x
A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma
Y. Enomoto (2012)
10.1378/CHEST.103.4_SUPPLEMENT.382S
Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma.
V. Rusch (1993)
10.1510/icvts.2010.245282
Acute postoperative cardiac herniation.
K. Kawamukai (2011)
10.1002/1097-0142(20010801)92:3<650::AID-CNCR1366>3.0.CO;2-0
Combined regimen of cisplatin, doxorubicin, and α‐2b interferon in the treatment of advanced malignant pleural mesothelioma
H. Parrà (2001)
10.1097/COC.0b013e3181d31f02
Expert Opinions of the First Italian Consensus Conference on the Management of Malignant Pleural Mesothelioma
C. Pinto (2011)
10.1016/0003-4975(94)90374-3
Summary of current cooperative group clinical trials in thoracic malignancies. The Thoracic Intergroup.
V. Rusch (1994)
10.1177/0218492312449633
Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis
Bassel Al-Alao (2012)
10.1016/j.ijrobp.2011.11.057
Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
P. Patel (2012)
10.1016/j.ijrobp.2009.06.037
Radiotherapy in malignant pleural mesothelioma.
M. McAleer (2009)
10.1016/0003-4975(94)90090-6
Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma.
W. Smythe (1994)
10.3978/j.issn.2072-1439.2013.11.28
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
N. van Zandwijk (2013)
10.1378/CHEST.116.SUPPL_3.446S
Surgical treatment of mesothelioma: pleurectomy.
J. Roberts (1999)
10.1016/B0-72-167494-1/50021-9
Primary Malignancies of the Thorax
R. Munden (2002)
10.1007/3-540-27329-8_8
Invasive Diagnostik und chirurgische Therapie
H. Dienemann (2005)
10.1016/S0304-5412(13)70499-2
Otros tumores torácicos: mesotelioma, timoma y tumores germinales mediastínicos
Fatima Navarro Expósito (2009)
A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.
A. Yamazaki (2005)
10.1007/s00259-010-1704-x
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival
V. Gerbaudo (2010)
10.1016/S0761-8425(06)71787-9
4.3. Place de la radiothérapie dans le mésothéliome pleural
C. Hennequin (2006)
10.1158/1078-0432.CCR-08-1579
Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
F. Vandermeers (2009)
10.1038/sj.bjc.6600920
Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
J. Edwards (2003)
10.1158/1078-0432.CCR-05-1191
Inhibition of the Met Receptor in Mesothelioma
T. Mukohara (2005)
10.1089/HUM.1996.7.18-2225
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.
J. Kucharczuk (1996)
10.1007/978-2-8178-0021-9_17
Mésothéliome pleural malin
J.-M. Bréchot (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar